Family · Pharmaceutical analytical standards
Mirogabalin
A gabapentinoid that binds the alpha-2-delta subunit of calcium channels in nerve fibres, first approved in Japan in January 2019 for peripheral neuropathic pain. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It lets go of the alpha-2-delta-1 subunit, linked to pain, much more slowly than alpha-2-delta-2: a dissociation half-life of about 11 hours versus 2.4. A deliberately selective grip.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
